Adlai Nortye’s Post

We are pleasured to announce that we have our first patient dosed in randomized Phase II clinical trial of Palupiprant (AN0025) for the treatment of locally advanced rectal cancer with radiation therapy.  Read more at https://lnkd.in/eCY6H479

To view or add a comment, sign in

Explore topics